Connor, Clark & Lunn Investment Management (CC&L)
AMLX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Amylyx Pharmaceuticals AMLX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$7.4M Sell
2025
Q1 		$4.25M Sell
2024
Q4 		$4.78M Buy
2024
Q3 		$2.85M Buy
2024
Q2 		$1.18M Buy
2024
Q1 		$1.5M Buy
2023
Q4 		$3.78M Buy
2023
Q3 		$2.28M Buy